Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö > °Ô³ð â¾à > Â÷¼¼´ë ½ÃÄö½Ì ±â¼ú : ÀÀ¿ë ¹× ½ÃÀå ¸®Æ÷Æ® - °³¿ä
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1590)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (51)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (54)
¹ÙÀÌ¿ÀÀåºñ (357)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (131)
À¯ÀüÀÚ Ä¡·á/RNAi (101)
Àç»ýÀÇÇÐ (124)
Ç×ü/¸é¿ª (191)
½ÃÀ庸°í¼­

Â÷¼¼´ë ½ÃÄö½Ì ±â¼ú : ÀÀ¿ë ¹× ½ÃÀå ¸®Æ÷Æ® - °³¿ä

Next-Generation Sequencing Technologies: Applications and Markets Report

¸®¼­Ä¡»ç Insight Pharma Reports
¹ßÇàÀÏ 2010³â 10¿ù »óǰÄÚµå 129401
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 3,195 £Ü 3,806,800 PDF by E-mail ( Single User License)
US $ 3,995 £Ü 4,760,000 PDF by E-mail ( Single Site License)
US $ 9,950 £Ü 11,855,400 PDF by E-mail ( Multi User License)


Insight Pharma Reports ¿¡¼­ 2010³â 10¿ù ¿¡ ¹ßÇàÇÑ ¡¸Â÷¼¼´ë ½ÃÄö½Ì ±â¼ú : ÀÀ¿ë ¹× ½ÃÀå ¸®Æ÷Æ® - °³¿ä¡¹ º¸°í¼­´Â US $3,195 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

Â÷¼¼´ë ½ÃÄö½Ì ±â¼ú(Next-Generation Sequencing Technologies) °³¿ä¿Í ±× ±âÃÊ ¿¬±¸, ÀÀ¿ë ¿¬±¸, ½ÃÀåÀÇ ±Ô¸ð¿Í µ¿Çâ µîÀ» Á¶»ç ºÐ¼®Çϰí, Àü¹®°¡ÀÇ °ßÇØ¸¦ ÇÔ²² ÀüÇØµå¸³´Ï´Ù.

    °³¿ä
    Á¦1Àå ¼­·Ð
    Á¦2Àå Â÷¼¼´ë ½ÃÄö½ÌÀÇ ÀÀ¿ë
    • Àΰ£ °Ô³ð ÇÁ·ÎÁ§Æ®
    • ÇöÀçÀÇ Â÷¼¼´ë ½ÃÄö½Ì ÀÀ¿ë °æ·Î
    • ¸ÂÃãÇü ÀÇ·á(Personalized Medicine) ÆÐ·¯´ÙÀÓÀÇ µîÀå
    Á¦3Àå ±âÃÊ ¿¬±¸
    • ÈÄ»ýÀ¯ÀüÇÐ(Epigenetics)
    • ChIP ½ÃÄö½Ì
    • RNA ½ÃÄö½Ì
    • Exome ½ÃÄö½Ì
    • ¸é¿ªÀ¯ÀüÇÐ(Immunogenetics)
    • Áúº´ÀÇ ¸ÞÄ¿´ÏÁò
    • ¸ÞŸ°Ô³ë¹Í½º(Metagenomics)
    • ¹ßÀü
    • ±âŸ
    Á¦4Àå ÀÀ¿ë ¿¬±¸
    • Áø´Ü
    • Drug Discovery
    • ³ó¾÷ ¹× µ¿¹° °Ô³ë¹Í½º
    • Â÷¼¼´ë ½ÃÄö½Ì °ü·Ã ÄÁ¼Ò½Ã¾ö°ú Á¦ÈÞ ÇÁ·ÎÁ§Æ®
    Á¦5Àå ½ÃÀå °ü·Ã ¹®Á¦
    • À¯Àú Á¶»ç °á°ú
    • ½ÃÀå±Ô¸ð, Ư¡, ¼ºÀå
    • Áø´ÜÀ¸·ÎÀÇ Àü°³
    • Â÷¼¼´ë ½ÃÄö½Ì ¹× ¸¶ÀÌÅ©·Î¾î·¹ÀÌ(Microarray) ½ÃÀå
    • Àΰ£°Ô³ð ½ÃÀåÀÇ ³íÀï
    • Exome ¹× ÀüÀå °Ô³ð ½ÃÄö½Ì
    Á¦6Àå °á·Ð°ú µ¿Çâ
    • °³ÀÎ °Ô³ë¹Í½º
    • Àü°³ ÇÁ·ÎÁ§Æ®
    • Á¶»çÀÇ °á·Ð
    Á¦7Àå Àü¹®°¡ÀÇ °ßÇØ
    Âü°í
    ±â¾÷ À妽º(À¥ÁÖ¼Ò Ã·ºÎ)
ksm
Back to Top